BARD1 serum autoantibodies for the detection of lung cancer.

BARD1 serum autoantibodies for the detection of lung cancer.

<h4>Purpose</h4>Currently the screening for lung cancer for risk groups is based on Computed Tomography (CT) or low dose CT (LDCT); however, the lung cancer death rate has not decreased significantly with people undergoing LDCT. We aimed to develop a simple reliable blood test for early...

Full description

Bibliographic Details
Main Authors: Maxim Pilyugin, Pascaline Descloux, Pierre-Alain André, Viktoria Laszlo, Balazs Dome, Balazs Hegedus, Sylvain Sardy, Samuel Janes, Andrea Bianco, Geoffrey J Laurent, Irmgard Irminger-Finger
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182356&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182356&type=printable

Similar Items